Middle East Pharmaceutical Industries Company (TADAWUL:4016)

Saudi Arabia flag Saudi Arabia · Delayed Price · Currency is SAR
102.90
-2.50 (-2.37%)
Apr 28, 2026, 3:12 PM AST
-20.23%
Market Cap 2.06B
Revenue (ttm) 460.48M
Net Income (ttm) 97.01M
Shares Out 20.00M
EPS (ttm) 4.85
PE Ratio 21.26
Forward PE n/a
Dividend 2.50 (2.37%)
Ex-Dividend Date Mar 30, 2026
Volume 56,640
Average Volume 115,163
Open 105.40
Previous Close 105.40
Day's Range 102.80 - 105.90
52-Week Range 94.30 - 139.00
Beta 0.47
RSI 54.84
Earnings Date Mar 26, 2026

About TADAWUL:4016

Middle East Pharmaceutical Industries Company engages in the research, development, manufacture, and marketing of generic medicines and pharmaceutical preparations in the Kingdom of Saudi Arabia and internationally. The company operates through three segments: Private, Public, and Export. Its product portfolio includes dermatological, respiratory, cardiovascular, alimentary and anti-infectives, musculoskeletal, genitourinary systems, and CNS. It exports its products. The company was formerly known as Middle East Chemical Products Factory Compan... [Read more]

Industry Medical - Pharmaceuticals
Sector Healthcare
Founded 1998
Employees 731
Stock Exchange Saudi Stock Exchange
Ticker Symbol 4016
Full Company Profile

Financial Performance

In 2025, TADAWUL:4016's revenue was 460.48 million, an increase of 16.87% compared to the previous year's 394.00 million. Earnings were 97.01 million, an increase of 21.49%.

Financial Statements

News

There is no news available yet.